Have you ever experienced a dull, gnawing pain in your stomach, persistent bloating, or frequent indigestion? If these symptoms sound familiar, you might be among the millions in India carrying a tiny spiral-shaped bacterium in your stomach without even realizing it. Its name is Helicobacter pylori (H. pylori).
In fact, 60–70% of India’s population is estimated to carry this infection, often without any symptoms. That means nearly a billion Indians may harbour these bacteria in the stomach. The high prevalence in India is largely attributed to a combination of crowded living conditions, limited access to clean water and sanitation, and dietary habits.
What Exactly Is H. pylori?
Helicobacter pylori is a unique type of bacteria that has adapted to stay alive in the very strong stomach acid in the human stomach. It’s a clever survivor; it produces an enzyme called urease, which changes urea into ammonia, neutralizing the stomach acid around it. It creates its own safe haven inside your stomach lining.
Once H. pylori colonizes your stomach, it typically stays there for life unless effectively treated with antibiotics, especially if you have symptoms regarding it. And while most people will never develop noticeable symptoms, for others, this silent resident can trigger a cascade of health problems, ranging from mild indigestion to life-threatening conditions.
How Is H. Pylori Transmitted? (And Why Is India at High Risk?)
The bacterium spreads primarily through two routes:
Fecal-Oral Route:
This is the most common pathway. Bacteria shed in an infected person’s stool contaminate food, water, or surfaces. Open defecation multiplies this risk dramatically.
Oro-Oral Route:
Saliva transmission: sharing utensils, drinking from the same glass, or even kissing an infected person can spread the bacteria if the person has regurgitation (contents of the stomach coming back to the mouth frequently).
Many Indians acquire H. pylori during the first decade of life.
Good household hygiene practices such as proper waste disposal, washing hands with soap after using the toilet, and regular use of boiled or purified drinking water can significantly reduce the risk of acquisition.
Symptoms: Why It’s Called the “Silent Invader”
The most deceptive thing about H. pylori infection is that most infected individuals never show any signs or symptoms. They go about their daily lives completely unaware of the bacteria inside them.
When symptoms do appear, they typically arise from inflammation or ulceration in the stomach or duodenum. Common red flags include:
- A burning or dull pain in the upper abdomen, often worse on an empty stomach or between meals
- Nausea and loss of appetite
- Frequent burping, bloating, or a feeling of fullness after eating very little
- Unintentional weight loss
Warning signs requiring immediate medical attention include black or bloody vomit, black or tarry stools (melena), or severe abdominal pain that disrupts sleep.
The Serious Complications: From Ulcers to Cancer
H. pylori is the primary cause of chronic gastritis, irritation of the inner lining of the stomach. Over time, this inflammation weakens the stomach’s protective barrier, allowing digestive acids to damage the tissue and create peptic ulcers (wounds in the lining of the upper digestive tract).
But the stakes go far beyond ulcers in a few individuals in India. The World Health Organization’s International Agency for Research on Cancer (IARC) classifies H. pylori as a group 1 carcinogen: a definite cause of stomach cancer in humans. Chronic, untreated H. pylori infection is the most important risk factor for gastric (stomach) cancer, as well as MALT lymphoma (a rare cancer of the stomach’s lymphatic tissue).
Most infected children remain symptom-free; approximately 15% may go on to have peptic ulcer disease in early adulthood, and 1% may get gastric cancer when they are older.
Breaking the Chain: Diagnosis and Treatment
One of the most promising developments in recent years is the introduction of simpler, non-invasive diagnostic methods.
· Conventional diagnosis relies on endoscopy with biopsy, an invasive procedure requiring sedation and specialized equipment. The rapid urease test (RUT) performed on biopsied tissue has sensitivities of 85–95% and specificities above 95%.
· Non-invasive options include the urea breath test (UBT) and stool antigen test (SAT). UBT, in particular, is highly accurate with sensitivity and specificity exceeding 90%.
Treatment usually consists of a 14-day course of a proton pump inhibitor.
PPI-clarithromycin-based triple therapy remains the preferred first-line regimen (67%), despite rising resistance.
A Note on Antibiotic Resistance: India’s Growing Challenge
The biggest obstacle to treatment success is antibiotic resistance.
What does this mean for you? If you have been prescribed antibiotics for other infections in the past, your H. pylori may already be resistant to certain drugs. Always complete the full course of medication exactly as prescribed by a registered medical practitioner; stopping early can contribute to resistance and treatment failure.
A Call to Action: What Can You Do?
For the General Public:
-
Practice Good Hygiene:
Wash your hands thoroughly with soap, especially after using the toilet and before eating. Use boiled or filtered drinking water.
-
Be Aware of the Signs:
Don’t dismiss persistent stomach pain, bloating, or nausea as “just gas”. If symptoms persist for more than two weeks, see a doctor.
-
Don’t Self-Medicate:
Avoid over-the-counter antacids or PPIs without a proper diagnosis; they may temporarily relieve symptoms but won’t eradicate the bacteria.
-
Get Tested if You Have Risk Factors:
If you have a family history of stomach cancer or ulcers, or belong to a high-prevalence region, discuss screening with your doctor.
The Final Word
H. pylori is a serious, transmissible infectious disease that affects the majority of Indians**. But it’s also largely preventable and treatable. With greater public awareness, improved hygiene, better access to diagnosis, and judicious use of antibiotics, we can significantly reduce the burden of ulcer disease and gastric cancer in India.
Dr. S. Vadivel Kumaran
Senior Consultant Gastroenterologist
Kauvery Hospital, Chennai
Happy Doctors’ Day!
With Gratitude for Every Step of My Journey to Recovery.
For a long time, I suffered from recurring, upsetting pain in my chest, epigastric region, and upper back, along with occasional breathlessness. The uncertainty was as exhausting as the pain itself — I made multiple trips to the ER, each time undergoing a complete cardiac workup that came back clear, only to be sent home on antacids. I consulted several doctors and went through round after round of trial-and-error medications, but nothing brought lasting relief.
An endoscopy eventually revealed that I was H. pylori positive, and I was started on the standard treatment regimen. Unfortunately, I couldn’t tolerate it — the side effects were significant, and I was back to square one, frustrated and unsure where to turn.
That changed when I met Dr. Vadivel Kumaran. He took the time to examine me thoroughly, did few tests and, more importantly, to actually listen. We had several in-depth conversations about my symptoms and history and based on the test results, he decided on a personalized, bismuth-containing H. pylori regimen tailored to what my body could tolerate. Within the first couple of days after strating the treatment, I could feel a significant symptom relief. After two weeks, my symptoms improved drastically — the chest, epigastric, and back pain were almost completely gone, and even my breathlessness had nearly disappeared. I am god willingly symptom free now.
I am deeply grateful to Dr. Vediveil Kumaran for his expertise, patience, and willingness to look beyond the standard playbook to find what actually worked for me. After months of searching for answers, his care made all the difference.
